Inogen (INGN) Cash & Current Investments (2012 - 2026)
Inogen (INGN) posted quarterly Cash & Current Investments of $110.2 million for Q1 2026, down 10.09% year-over-year from $122.5 million in Q1 2025, and up 4.91% quarter-over-quarter from $105.0 million in Q4 2025.
Inogen (INGN) Cash & Current Investments (2012 - 2026) Analysis & Trends
Inogen (INGN) has reported Cash & Current Investments for 15 consecutive years, with $110.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 10.09% year-over-year to $110.2 million; the TTM figure through Mar 2026 stood at $110.2 million (down 10.09% YoY), while the FY2025 annual figure was $105.0 million, down 13.23% from the prior year.
- Cash & Current Investments grew to $110.2 million in Q1 2026 per INGN's latest filing, from $105.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $223.4 million in Q1 2022 and bottomed at $34.8 million in Q2 2022.
- Historically, Cash & Current Investments has averaged $115.9 million across 5 years, with a median of $117.7 million in 2024.
- On a YoY basis, Cash & Current Investments climbed as much as 261.22% in 2022 and fell as far as 86.1% in 2022.
- Inogen's Cash & Current Investments stood at $206.0 million in 2022, then plunged by 37.62% to $128.5 million in 2023, then decreased by 5.79% to $121.0 million in 2024, then dropped by 13.23% to $105.0 million in 2025, then rose by 4.91% to $110.2 million in 2026.
- Business Quant data shows INGN's Cash & Current Investments at $110.2 million in Q1 2026, $105.0 million in Q4 2025, and $107.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Inogen | 151.86 Mn | 46.32 Mn | 43.27 Mn | 105.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.54 Mn |
| Mar 31, 2026 | 110.17 Mn |
| Dec 31, 2025 | 105.02 Mn |
| Sep 30, 2025 | 107.76 Mn |
| Jun 30, 2025 | 122.43 Mn |
| Mar 31, 2025 | 122.54 Mn |
| Dec 31, 2024 | 121.04 Mn |
| Sep 30, 2024 | 109.28 Mn |
| Jun 30, 2024 | 117.69 Mn |
| Mar 31, 2024 | 119.81 Mn |
| Dec 31, 2023 | 128.47 Mn |
| Sep 30, 2023 | 37.17 Mn |
| Jun 30, 2023 | 47.61 Mn |
| Mar 31, 2023 | 38.78 Mn |
| Dec 31, 2022 | 205.95 Mn |
| Sep 30, 2022 | 218.11 Mn |
| Jun 30, 2022 | 34.76 Mn |
| Mar 31, 2022 | 223.39 Mn |
| Dec 31, 2021 | 245.51 Mn |
| Sep 30, 2021 | 245.13 Mn |